News | May 07, 2021
Roche receives emergency use authorisation of COVID-19 drug
This Emergency Use Authorisation will now enable Roche to import the globally manufactured product batches to India
This Emergency Use Authorisation will now enable Roche to import the globally manufactured product batches to India
Apart from the above, it was also decided that Basic Customs Duty on import of COVID-19 vaccines be also exempted with immediate effect for a period of 3 months
The country has constantly worked with the spirit of public-private partnership
The merger is in line with Solara’s strategy of accelerating growth via appropriate inorganic actions
The government has taken all the effective measures to make healthcare affordable
Report outlines the wide array of investment opportunities in various segments of India’s healthcare sector
Integration of various regulatory agencies with a single-window system and putting in place a transparent, stable, predictable and easy to navigate interface.
NPPA also fixed retail price of 76 new drugs in the meeting dated 10th March 2021 to be launched by existing manufacturers including off-patent Anti-diabetic drugs allowing due benefit of patent expiry to the patients.
AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.
The next phase of growth in pharma depends on the industry-oriented workforce, risk investment, academic revamp, and creation of R&D hubs, say experts .
Subscribe To Our Newsletter & Stay Updated
